Anemia, red blood cell transfusion and administration of blood products in obstetrics: a nationwide analysis of more than 6 million cases from 2011-2020
DISCUSSION: The prevalence of anemia and the increased risk for RBC transfusion show that there is great potential for effective implementation of PBM in obstetrics. The treatment of anemia during pregnancy and reduction of RBC transfusions will decrease maternal morbidity and mortality.PMID:37847205 | DOI:10.2450/BloodTransfus.528 (Source: Blood Transfusion)
Source: Blood Transfusion - October 17, 2023 Category: Hematology Authors: Jan A Kloka Benjamin Friedrichson Thomas Jasny Oliver Old Florian Piekarski Kai Zacharowski Vanessa Neef Source Type: research
Their health is our wealth: lay perceptions on the health impacts of blood donation
Blood Transfus. 2023 Sep 22. doi: 10.2450/BloodTransfus.625. Online ahead of print.NO ABSTRACTPMID:37847206 | DOI:10.2450/BloodTransfus.625 (Source: Blood Transfusion)
Source: Blood Transfusion - October 17, 2023 Category: Hematology Authors: Helen Fogarty Ellen McSweeney Tor Hervig Source Type: research
Original article Pretreatment with daudi cells eliminates anti-cd47 monoclonal antibody interference in immunohematology testing
DISCUSSION: By decreasing the incubation time, we discovered that interferences in samples with agglutination strengths below 2+ could be eliminated after incubation for 5 min. Of importance, Daudi cells can be preserved with 4% paraformaldehyde for 14 days as short-term storage reagents. This is the first study in which Daudi cells were used to effectively resolve the interference of anti-CD47 monoclonal antibodies in pretransfusion tests.PMID:37847207 | DOI:10.2450/BloodTransfus.539 (Source: Blood Transfusion)
Source: Blood Transfusion - October 17, 2023 Category: Hematology Authors: Hua Wei Ying Cui Dongxia Ren Xia Jiang Wenda Fu Shijie Mu Longfei Yang Jie Chen Source Type: research
Challenges in perioperative blood transfusions in kidney transplantation and the need for Patient Blood Management
CONCLUSIONS: In conclusion, PBM guidelines should be applied to patients on the KTx deceased donor waiting list and especially those scheduled to receive a transplant from a living donor. This could potentially increase the utilization efficiency of blood products and avoid transfusion-related severe adverse effects.PMID:37847208 | DOI:10.2450/BloodTransfus.577 (Source: Blood Transfusion)
Source: Blood Transfusion - October 17, 2023 Category: Hematology Authors: Diana Rodr íguez-Espinosa Jos é J Broseta Anney Rosario Judit Cacho Beatriz Tena Elena Cuadrado-Payan Rams és Marrero Beatriu Bay és Nuria Esforzado Mireia Musquera Fritz Diekmann Aleix Cases Misericordia Basora Source Type: research
Toward a definition of immunological risk for patients with anti-HLA antibodies before stem cell transplantation
Blood Transfus. 2023 Sep 21. doi: 10.2450/BloodTransfus.630. Online ahead of print.NO ABSTRACTPMID:37847209 | DOI:10.2450/BloodTransfus.630 (Source: Blood Transfusion)
Source: Blood Transfusion - October 17, 2023 Category: Hematology Authors: Roberto Crocchiolo Source Type: research
Use of a recombinant deacetylase to convert A < sub > 1 < /sub > red blood cells to the acquired B phenotype for quality control purposes
Blood Transfus. 2023 Sep 20. doi: 10.2450/BloodTransfus.584. Online ahead of print.NO ABSTRACTPMID:37847210 | DOI:10.2450/BloodTransfus.584 (Source: Blood Transfusion)
Source: Blood Transfusion - October 17, 2023 Category: Hematology Authors: Jennifer Ricci Hagman Peter Rahfeld Stephen G Withers Jayachandran N Kizhakkedathu Martin L Olsson Jill R Storry Source Type: research
Donor specific anti-HLA antibodies in hematopoietic stem cell transplantation. Single Center prospective evaluation and desensitization strategies employed
CONCLUSIONS: Our study confirms the importance to test DSAs in mismatched-hematopoietic stem cells transplantation The DS used proved successful in removing DSAs. Prospective multicenter studies are needed to better define and validate consensus strategies on DSA management in HSCT.PMID:37847211 | DOI:10.2450/BloodTransfus.464 (Source: Blood Transfusion)
Source: Blood Transfusion - October 17, 2023 Category: Hematology Authors: Ursula La Rocca Maria P Perrone Alfonso Piciocchi Walter Barberi Paola Gesuiti Luca Laurenti Paola Cinti Maria Gozzer Manhaz Shafii Bafti Daniela Carmini Nadia Cinelli Claudio Cavallari Gianluca Giovannetti Roberto Ricci Gabriella Girelli Robin Fo à Maur Source Type: research
XVIII Convegno Triennale sui Problemi Clinici e Sociali dell'Emofilia, Napoli, 12-15 ottobre 2023
Blood Transfus. 2023 Oct 12. doi: 10.2450/BloodTransfus.2023.Suppl4. Online ahead of print.NO ABSTRACTPMID:37847212 | DOI:10.2450/BloodTransfus.2023.Suppl4 (Source: Blood Transfusion)
Source: Blood Transfusion - October 17, 2023 Category: Hematology Authors: Antonio Coppola Angiola Rocino Rita Carlotta Santoro Angelo Claudio Molinari Cristina Santoro Ezio Zanon Source Type: research
Anemia, red blood cell transfusion and administration of blood products in obstetrics: a nationwide analysis of more than 6 million cases from 2011-2020
DISCUSSION: The prevalence of anemia and the increased risk for RBC transfusion show that there is great potential for effective implementation of PBM in obstetrics. The treatment of anemia during pregnancy and reduction of RBC transfusions will decrease maternal morbidity and mortality.PMID:37847205 | DOI:10.2450/BloodTransfus.528 (Source: Blood Transfusion)
Source: Blood Transfusion - October 17, 2023 Category: Hematology Authors: Jan A Kloka Benjamin Friedrichson Thomas Jasny Oliver Old Florian Piekarski Kai Zacharowski Vanessa Neef Source Type: research
Their health is our wealth: lay perceptions on the health impacts of blood donation
Blood Transfus. 2023 Sep 22. doi: 10.2450/BloodTransfus.625. Online ahead of print.NO ABSTRACTPMID:37847206 | DOI:10.2450/BloodTransfus.625 (Source: Blood Transfusion)
Source: Blood Transfusion - October 17, 2023 Category: Hematology Authors: Helen Fogarty Ellen McSweeney Tor Hervig Source Type: research
Original article Pretreatment with daudi cells eliminates anti-cd47 monoclonal antibody interference in immunohematology testing
DISCUSSION: By decreasing the incubation time, we discovered that interferences in samples with agglutination strengths below 2+ could be eliminated after incubation for 5 min. Of importance, Daudi cells can be preserved with 4% paraformaldehyde for 14 days as short-term storage reagents. This is the first study in which Daudi cells were used to effectively resolve the interference of anti-CD47 monoclonal antibodies in pretransfusion tests.PMID:37847207 | DOI:10.2450/BloodTransfus.539 (Source: Blood Transfusion)
Source: Blood Transfusion - October 17, 2023 Category: Hematology Authors: Hua Wei Ying Cui Dongxia Ren Xia Jiang Wenda Fu Shijie Mu Longfei Yang Jie Chen Source Type: research
Challenges in perioperative blood transfusions in kidney transplantation and the need for Patient Blood Management
CONCLUSIONS: In conclusion, PBM guidelines should be applied to patients on the KTx deceased donor waiting list and especially those scheduled to receive a transplant from a living donor. This could potentially increase the utilization efficiency of blood products and avoid transfusion-related severe adverse effects.PMID:37847208 | DOI:10.2450/BloodTransfus.577 (Source: Blood Transfusion)
Source: Blood Transfusion - October 17, 2023 Category: Hematology Authors: Diana Rodr íguez-Espinosa Jos é J Broseta Anney Rosario Judit Cacho Beatriz Tena Elena Cuadrado-Payan Rams és Marrero Beatriu Bay és Nuria Esforzado Mireia Musquera Fritz Diekmann Aleix Cases Misericordia Basora Source Type: research
Toward a definition of immunological risk for patients with anti-HLA antibodies before stem cell transplantation
Blood Transfus. 2023 Sep 21. doi: 10.2450/BloodTransfus.630. Online ahead of print.NO ABSTRACTPMID:37847209 | DOI:10.2450/BloodTransfus.630 (Source: Blood Transfusion)
Source: Blood Transfusion - October 17, 2023 Category: Hematology Authors: Roberto Crocchiolo Source Type: research
Use of a recombinant deacetylase to convert A < sub > 1 < /sub > red blood cells to the acquired B phenotype for quality control purposes
Blood Transfus. 2023 Sep 20. doi: 10.2450/BloodTransfus.584. Online ahead of print.NO ABSTRACTPMID:37847210 | DOI:10.2450/BloodTransfus.584 (Source: Blood Transfusion)
Source: Blood Transfusion - October 17, 2023 Category: Hematology Authors: Jennifer Ricci Hagman Peter Rahfeld Stephen G Withers Jayachandran N Kizhakkedathu Martin L Olsson Jill R Storry Source Type: research
Donor specific anti-HLA antibodies in hematopoietic stem cell transplantation. Single Center prospective evaluation and desensitization strategies employed
CONCLUSIONS: Our study confirms the importance to test DSAs in mismatched-hematopoietic stem cells transplantation The DS used proved successful in removing DSAs. Prospective multicenter studies are needed to better define and validate consensus strategies on DSA management in HSCT.PMID:37847211 | DOI:10.2450/BloodTransfus.464 (Source: Blood Transfusion)
Source: Blood Transfusion - October 17, 2023 Category: Hematology Authors: Ursula La Rocca Maria P Perrone Alfonso Piciocchi Walter Barberi Paola Gesuiti Luca Laurenti Paola Cinti Maria Gozzer Manhaz Shafii Bafti Daniela Carmini Nadia Cinelli Claudio Cavallari Gianluca Giovannetti Roberto Ricci Gabriella Girelli Robin Fo à Maur Source Type: research
